Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 May 11;12(7):1690–1701. doi: 10.1158/2159-8290.CD-21-1486

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©2022 The Authors; Published by the American Association for Cancer Research

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.

PMC Copyright notice

Figure 4. Sensitivity analysis and treatment history of 47 recurred patients. A, Sensitivity analysis of MRD detection at landmark, longitudinal, and surveillance time points. B, Treatment and MRD test history of all 47 recurred patients. Chemo, chemotherapy; ICI, immune-checkpoint inhibitor; TKI, tyrosine kinase inhibitor. — Sensitivity analysis and treatment history of 47 patients with recurrence. A, Sensitivity analysis of MRD detection at landmark, longitudinal, and surveillance time points. B, Treatment and MRD test history of all 47 patients with recurrence. Chemo, chemotherapy; TKI, tyrosine kinase inhibitor.